Table 1.

Baseline characteristics of trial patients in the PHOTOSTENT-02 trial

	PDT+stenting n=46 N (%)	Stenting alone n=46 N (%)
Sex
Male	29 (63)	26 (57)
Female	17 (37)	20 (43)
Disease status
Locally advanced	32 (70)	34 (74)
Metastatic	14 (30)	12 (26)
Primary tumour site
Gallbladder	3 (7)	5 (11)
Bile duct	43 (93)	41 (89)
Prior therapy
None	36 (78)	37 (80)
Chemotherapy	7 (15)	7 (15)
Other	3 (7)	2 (4)
ECOG performance status
0	15 (33)	14 (30)
1	21 (46)	20 (43)
2	9 (20)	10 (22)
3	1 (2)	2 (4)
Age (years), median (IQR)	67.7 (62.8–72.8)	67.3 (60.4–74.2)